FineCell
Financials
Estimates*
EUR | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 |
---|---|---|---|---|---|---|
Revenues | <1m | <1m | - | <1m | <1m | <1m |
% growth | - | 68 % | - | - | (30 %) | 96 % |
EBITDA | - | - | - | (<1m) | (<1m) | (<1m) |
% EBITDA margin | - | - | - | (484 %) | (7193 %) | (17976 %) |
Profit | (<1m) | <1m | <1m | (<1m) | (<1m) | (<1m) |
% profit margin | (1 %) | 1 % | - | (700 %) | (7568 %) | (18339 %) |
Source: Dealroom estimates
Date | Investors | Amount | Round |
---|---|---|---|
N/A | Spinout | ||
* | N/A | Seed | |
€210k | Seed | ||
N/A | - | ||
* | €1.0m | Seed | |
Total Funding | €1.2m |
Recent News about FineCell
EditFineCell is a pioneering company specializing in the development and production of micro and nanocellulose, a versatile and sustainable bio-based material. The company operates in the personal care and consumer goods markets, providing eco-friendly alternatives to fossil-based and harmful chemicals. FineCell's patented technology allows for the creation of high-performance materials that meet current market demands and anticipate future needs. The business model revolves around B2B collaborations, offering solutions to companies looking to reduce their carbon footprint and develop greener products. Revenue is generated through the sale of these advanced materials to specialists in cosmetics, paints, thin film applications, and 3D bioprinting. FineCell's commitment to sustainability and innovation positions it as a key player in the transition to a bio-based economy.
Keywords: microcellulose, nanocellulose, bio-based materials, sustainability, personal care, consumer goods, eco-friendly, B2B, carbon footprint, innovation.